Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Sylvester who wrote (856)	5/1/1998 6:55:00 PM
From: E	Read Replies (2) \| Respond to of 4140

" Today's action seems to refute this news, any comments. " Yes-- that was posted on Yahoo at 10:30 in the morning yesterday. It just seems odd, if it wasn't some hypster, that the stock would be down today... Loren? Rainier? Do you guys have any thoughts about this?

To: Sylvester who wrote (856)	5/1/1998 11:05:00 PM
From: HeyRainier	Read Replies (2) \| Respond to of 4140

[ Hypists, Rumors, and SNRS Stock Price Observations ] Regarding the rumors: I don't buy it. I don't suggest that the participants of the thread let their investment decisions be influenced by far-fetched rumors. If the rumors were indeed true, we would have had a continuation of the near term upward price movement. Instead, we closed down 6% today. However, fund managers indeed have their hands tied when it comes to acquiring issues that are below certain capitalization levels. That includes most issues below $5, and certainly BB stocks. Fund managers have their butts to cover as well, and they will not risk the ire of their clients just for the sake of a potentially higher return from a stock as unknown as SNRS. I believe that was a message that was similarly noted in Peter Lynch's One Up on Wall Street. Fund managers are tied, and will not be able to buy into a story until after various analysts have covered the issue and the company has established a widespread following. That leaves the individual investor with a tremendous advantage if he/she spots an opportunity at the ground floor. Now, regarding the stock price: I believe that others wishing to acquire SNRS at lower prices may have an opportunity in the near term. I did not like yesterday's Candle, particularly since it was doubly confirmed when the price pulled back after it hit a key retracement level near yesterday's highs. After seeing these developments, I and another I advise closed our "Swing" Position (acquired at an average price of $7.75) yesterday at a price a bit below $8.50. Of that position, I have decided to continue holding about 30% of it for trend-following purposes, and will let the price fluctuations iron itself out as the issue continues its upward advance. With these developments, the boundaries of a short term downtrend have materialized for SNRS' stock price, which I expect will set up the possibility of an even stronger upward move come breakout time for this issue. I believe that more significant support will materialize at a point where the price coincides with some key moving averages. It is fast approaching these levels. Currently, the trend remains bullish, and I continue to hold my intermediate term "teens-level" target, which I believe is in line with the expectations of the opthalmologists you confer with. Regards, Rainier